Mutation prevalence of cerebral cavernous malformation genes in Spanish patients

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Mondéjar, Rufino ^a   Solano, Francisca ^a   Rubio, Rocío ^a   Delgado, Mercedes ^a   Pérez Sempere, Ángel ^b   González Meneses, Antonio ^c   Vendrell, Teresa ^d   Izquierdo, Guillermo ^a   Martinez Mir, Amalia ^c   Lucas, Miguel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BUDD CHIARI SYNDROME; CAVERNOUS HEMANGIOMA; CCM1 GENE; CCM2 GENE; CCM3 GENE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; EXON; FEMALE; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MENARCHE; MIGRAINE; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; NOONAN SYNDROME; PREDICTION; PREVALENCE; RNA ANALYSIS; RNA SPLICING; SEIZURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CARRIER PROTEINS; CHILD; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTO-ONCOGENE PROTEINS; SEQUENCE DELETION; SPAIN; YOUNG ADULT;

EID: 84899807631     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086286     Document Type: Article

References (22)

1. Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, et al. (1998) Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 7: 1851-1858. (Pubitemid 28499416)
2. Laberge-le CS, Jung HH, Labauge P, Houtteville JP, Lescoat C, et al. (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23: 189-193. (Pubitemid 29455391)
3. Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, et al. (1999) Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8: 2325-2333. (Pubitemid 29525349)
4. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, et al. (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosinebinding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73: 1459-1464. (Pubitemid 38037437)
5. Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, et al. (2005) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76: 42-51. (Pubitemid 40023764)
6. Cave-Riant F, Denier C, Labauge P, Cecillon M, Maciazek J, et al. (2002) Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations. Eur J Hum Genet 10: 733-740. (Pubitemid 35460583)
7. Verlaan DJ, Siegel AM, Rouleau GA (2002) Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation. Am J Hum Genet 70: 1564-1567. (Pubitemid 34533903)
8. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, et al. (2005) CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14: 2521-2531. (Pubitemid 41236065)
9. Harel L, Costa B, Tcherpakov M, Zapatka M, Oberthuer A, et al. (2009) CCM2 mediates death signaling by the TrkA receptor tyrosine kinase. Neuron 63: 585-591.
10. Faurobert E, biges-Rizo C (2010) Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J 277: 1084-1096.
11. Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, et al. (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74: 326-337. (Pubitemid 38168620)
12. Riant F, Cecillon M, Saugier-Veber P, Tournier-Lasserve E (2013) CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions. Neurogenetics 14: 133-141.
13. D'Angelo R, Scimone C, Rinaldi C, Trimarchi G, Italiano D, et al. (2012) CCM2 gene polymorphisms in Italian sporadic patients with cerebral cavernous malformation: a case-control study. Int J Mol Med 29: 1113-1120.
14. Ortiz L, Costa AF, Bellido ML, Solano F, Garcia-Moreno JM, et al. (2007) Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene). J Neurol 254: 322-326. (Pubitemid 46399192)
15. Felbor U, Gaetzner S, Verlaan DJ, Vijzelaar R, Rouleau GA, et al. (2007) Large germline deletions and duplication in isolated cerebral cavernous malformation patients. Neurogenetics 8: 149-153. (Pubitemid 46356248)
16. Kim J, Sherman NE, Fox JW, Ginsberg MH (2011) Phosphorylation sites in the cerebral cavernous malformations complex. J Cell Sci 124: 3929-3932.
17. Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, et al. (2006) Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat 27: 118.
18. Pagani F, Baralle FE (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5: 389-396. (Pubitemid 38529410)
19. Kehrer-Sawatzki H, Wilda M, Braun VM, Richter HP, Hameister H (2002) Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1). Acta Neuropathol 104: 231-240. (Pubitemid 36082782)
20. Dammann P, Wrede KH, Maderwald S, El HN, Mueller O, et al. (2013) The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI. J Neurol Neurosurg Psychiatry 84: 194-200.
21. D'Angelo R, Marini V, Rinaldi C, Origone P, Dorcaratto A, et al. (2011) Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation. Brain Pathol 21: 215-224.
22. Verlaan DJ, Laurent SB, Rochefort DL, Liquori CL, Marchuk DA, et al. (2004) CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations. Ann Neurol 55: 757-758. (Pubitemid 38544342)